Full Event Guide
The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical development, translation, manufacturing, supply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.
400+ experts from pharma, biotech and leading academia are expected to attend in Boston next May 2022 to uncover best-in-class approaches to overcome.
Join the movement to revolutionize a universal cell therapy!
Hear What Previous Attendees Have to Say;
“The Allogeneic Cell Therapies Summit greatly covered the landscape of the field with outstanding presentations and discussions.”
– CSO, Pluto
“Very informative summit with lots of great material, knowledgeable and engaging speakers and overall a fantastic experience.”
– Non-clinical Safety Lead, Johnson & Johnson
“This was a very nice event. The focus on Allogeneic was really good and this summit provided an opportunity to have a more holistic view of the field and its potential. Very well done!”
– Chief Operations Officer, Celyad
“The Allogeneic Cell Therapies Summit highlighted key advances and outstanding challenges of what remains a very much ‘up and coming’ and rapidly evolving arm of immunotherapy.”
– Associate Director, Allogeneic Development, Triumvira Immunologics
“The quality of the presentations and diverse topics covered within the allogeneic cell therapy field were top notch.”
– Senior Scientist, Immatics